410 Medical has developed a simple, intuitive solution that allows a single healthcare provider to rapidly deliver fluid to critically ill patients, improving care and saving lives. Their device allows fast set-up, improves resuscitation speed, minimizes provider fatigue, and frees providers to address other patient care issues simultaneously. This solution is particularly useful in pre-hospital settings and the emergency department, where speed is critical and resources may be limited. It was founded in 2013 and is headquartered in Durham, North Carolina.

5Metis is a new pure-play discovery company for crop health. The company is the result of a union of Boragen and AgriMetis platforms, to combine boron-based small molecule discovery and synthetic biology for discovering new modes of action.

A1 BioChem Labs is a contract research organization that offers chemistry services to pharmaceutical companies.

Accord Healthcare is an emerging large-scale provider of generic pharmaceuticals. Accord is the commercial arm of Intas Pharmaceuticals, a pioneering biopharmaceutical company operating in India since 1976. Selling in over 70 countries, Accord has a vast global presence.

Developer of rapid diagnostic and data systems.

Adámas Nano is a manufacturer of nanodiamond. Their product categories include bioconjugated fluorescent nanodiamonds, functionalized nanodiamonds, single proton emitters, fluorescent micro diamonds, detonation powder, detonation nanodiamond suspensions, boron-doped nanodiamonds, CVD seeding suspensions, and nanodiamond polish.

Archer Daniels Midland Company offers food ingredients, animal feeds and feed ingredients, biofuels, and other products. ADM transforms natural products into a complete portfolio of ingredients and flavors for foods and beverages, supplements, nutrition for pets and livestock, and more. It was formed in 1902 and is headquartered in Chicago, Illinois.

AimMax Therapeutics engages in the research and development of pharmaceuticals at various stages of development.

AIXIAL operates as a Clinical Research Organization. It offers a range of services including clinical development, data management, and regulatory affairs. The company specializes in life sciences and is known for its expertise in conducting efficient clinical trials. AIXIAL also provides support across all therapeutic areas and is recognized for its reliability in the field. The company's diverse projects offer unique opportunities for its employees.

Manufacturer of amino acid-based products and food ingredients intended for the Pharmaceutical, Nutraceutical, Sports Nutrition, Health, and Beauty industries. The company offers research, development, and marketing for amino acid-based products that are animal filler-free and provides food ingredient solutions like sugar and fat reduction, taste improvement, and bonding, as well as wellness and sports nutrition products that help in increasing muscle building and endurance, enabling nutrition and health providers to create better lives for all.

Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. Founded and incubated by MPM Capital, the company has developed proprietary platforms to generate tumor-targeting agents with ideal properties for alpha radiotherapy. Designed for high tumor penetration and long residence time, Aktis Oncology's molecules will quickly clear other areas of the body, thereby maximizing tumor elimination while minimizing the side effects of treatment. This approach would also enable clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes.

Alcami is a US-based contract development and manufacturing organization headquartered in NC with 45+ years of experience advancing pharmaceuticals and biologics from development to delivery. Alcami provides fully integrated lab services, drug product manufacturing, and cGMP pharma storage and support services including environmental monitoring, calibration, and validation. Alcami’s private equity ownership includes GHO Capital, The Vistria Group, and Ampersand Capital Partners.